SPHS
Sophiris Bio, Inc.
SPHS
SPHS
Delisted
SPHS was delisted on the 11th of March, 2020.
35 hedge funds and large institutions have $6.73M invested in Sophiris Bio, Inc. in 2018 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 6 increasing their positions, 7 reducing their positions, and 1 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more capital invested
Capital invested by funds: $ → $
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
45% less call options, than puts
Call options by funds: $412K | Put options by funds: $752K
Holders
35
Holding in Top 10
–
Calls
$412K
Puts
$752K
Top Buyers
| 1 | +$484K | |
| 2 | +$126K | |
| 3 | +$67.7K | |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$31.5K |
| 5 |
Bank of New York Mellon
New York
|
+$28.5K |
Top Sellers
| 1 | -$250K | |
| 2 | -$55.1K | |
| 3 | -$43.3K | |
| 4 |
Simplex Trading
Chicago,
Illinois
|
-$31.8K |
| 5 |
Barclays
London,
United Kingdom
|
-$30.7K |